| Jun 20 |
Novavax: New Chapter, Questions Remain
|
| Jun 18 |
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine
|
| Jun 18 |
3 Short-Squeeze Stocks Ready to Break the Chains of Bearish Sentiment
|
| Jun 18 |
Novavax’s South African Phase IIb COVID-19 vaccine trial likely to reveal results within next fortnight, source says
|
| Jun 17 |
Novavax: Bird Flu And COVID-19 Headlines Trigger Rally
|
| Jun 17 |
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial Company'
|
| Jun 17 |
Novavax seeks FDA approval for updated Covid-19 vaccine
|
| Jun 14 |
Novavax seeks FDA authorization for updated JN.1 COVID shot
|
| Jun 14 |
Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
|
| Jun 13 |
FDA recommends KP.2 strain be used in updated COVID-19 shots
|
